Correction: Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma

類似資料

• Correction: Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma
  著者:: Shinsuke Suzuki, 等
  出版事項: (2025-10-01)
• Characterizations of sf-simple extension of topologies
  著者:: Mohammed Yaseen, 等
  出版事項: (2022-02-01)
• A Novel Transgenic Sf9 Cell Line for Quick and Easy Virus Quantification
  著者:: Kyu-Seek Kim, 等
  出版事項: (2024-09-01)
• SF-36 questionnaire population quality of life indices Objective
  著者:: V N Amirdjanova, 等
  出版事項: (2008-02-01)
• Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
  著者:: Luc Rochette, 等
  出版事項: (2020-05-01)